INS-406

N/A

Report date: 2025/01/26 15:38:35

Base Information

Drug NameINS-406
Drug Alias Nameacylated insulin analog (Novo Nordisk/Vanderbilt University)INS-406
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInsulin receptor agonistsInsulin ligand
TargetsInsulin receptor
Therapy Area/IndicationsHyperglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHyperglycemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A